These authors have demonstrated that c-kit can trigger apoptosis in various cancer cells and, more intriguingly, its pro-apoptotic activity could not be detected upon SCF binding, suggesting that c-kit may act both as a proto-oncogene via its kinase activity and as a tumor suppressor via its dependence receptor activity. The gene discussed is KIT; the disease is cancer.